Glycomine, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.glycomine.com
Clinical Trials
6
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDG
- Conditions
- Phosphomannomutase 2 DeficiencyPMM2-CDG
- Interventions
- Drug: GLM101 (Part A, Double-blind)Drug: Placebo (Part A, Double-blind)Drug: GLM101 (Part B, Open-label)
- First Posted Date
- 2025-03-24
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- Glycomine, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT06892288
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Seattle Children's Hospital, Seattle, Washington, United States
A Long-Term Study with GLM101 in Patients with PMM2-CDG
- Conditions
- PMM2-CDG
- First Posted Date
- 2024-06-21
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Glycomine Inc.
- Target Recruit Count
- 39
- Registration Number
- 2024-512171-12-00
- Locations
- 🇪🇸
Sant Joan De Deu Barcelona Hospital, Esplugues De Llobregat, Spain
24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG
- Conditions
- Pmm2-CDGPhosphomannomutase 2 Deficiency
- Interventions
- First Posted Date
- 2022-09-22
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Glycomine, Inc.
- Target Recruit Count
- 44
- Registration Number
- NCT05549219
- Locations
- 🇺🇸
Clinical Research of West Florida, Tampa, Florida, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
🇪🇸Hospital Sant Joan de Déu, Barcelona, Spain
Natural History Study Protocol in PMM2-CDG (CDG-Ia)
- Conditions
- Phosphomannomutase 2 Deficiency
- First Posted Date
- 2017-06-01
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- Glycomine, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT03173300
- Locations
- 🇺🇸
Mayo Clinic College of Medicine, Rochester, Minnesota, United States
🇺🇸Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, United States
🇺🇸Seattle Children's Hospital, Seattle, Washington, United States